Clinical trial
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
NCT02701283 · Medtronic Cardiovascular, Industry · Active, not recruiting
Key facts
| NCT number | NCT02701283 |
|---|---|
| Title | Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients |
| Official title | Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement |
| Lead sponsor | Medtronic Cardiovascular, Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Aortic Valve Stenosis |
| Intervention type | Device |
| Interventions | Medtronic Transcatheter Aortic Valve Replacement Systems, Surgical Aortic Valve Replacement (SAVR) |
| Enrollment | 2,223 |
| Start date | Mar 1, 2016 |
| Primary completion | Apr 1, 2021 |
| Completion | Mar 1, 2026 |
| First posted | Mar 8, 2016 |
| Last update posted | Oct 21, 2025 |
| Countries | Australia, Canada, France, Japan, Netherlands, New Zealand, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: